摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Brommethyl-1,2,4-benzothiadiazin-1,1-dioxid | 90221-49-1

中文名称
——
中文别名
——
英文名称
3-Brommethyl-1,2,4-benzothiadiazin-1,1-dioxid
英文别名
3-bromomethyl-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide;3-(bromomethyl)-4H-1λ6,2,4-benzothiadiazine 1,1-dioxide
3-Brommethyl-1,2,4-benzothiadiazin-1,1-dioxid化学式
CAS
90221-49-1
化学式
C8H7BrN2O2S
mdl
——
分子量
275.126
InChiKey
WWSKZXQZSNBLGT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    420.3±47.0 °C(Predicted)
  • 密度:
    1.87±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.59
  • 重原子数:
    14.0
  • 可旋转键数:
    1.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    58.53
  • 氢给体数:
    1.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Raffa,L. et al., Farmaco, Edizione Scientifica, 1962, vol. 17, p. 679 - 689
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    1,2,4-Benzothiadiazine derivatives as α1 and 5-HT1A receptor ligands
    摘要:
    A series of new 1,2,4-benzothiadiazine derivatives with an arylpiperazine mojety linked at position 3 of the heterocyclic ring were synthesized and assessed for their pharmacological profiles at alpha(1)-adrenoceptor subtypes (alpha(1A), alpha(1B) and alpha(1D)) by functional experiments and by in vitro binding studies at human cloned 5-HT1A receptor. Compound I was identified as a novel (alpha(1D) antagonist (pK(b)alpha(1D) = 7.59; alpha(1D)/alpha(1A) > 389; alpha(1D)/alpha(1B) = 135) with high selectivity over 5-HT1A receptor (5-HT1A/alpha(1D) < 0.01), while compound 6, a 3,4-dihydro-derivative, was characterized as a novel 5-HT1A receptor ligand, highly selective over alpha(1D)-adrenoceptor subtype (pK(i)5-HT1A = 8.04; 5-HT1A/alpha(1D) = 1096). Further pharmacological studies demonstrated that 6 is a partial agonist at 5-HT1A receptor (E-max = 23, pD(2) = 6.92). (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2004.12.004
点击查看最新优质反应信息